跳至主要内容
临床试验/NCT04068961
NCT04068961已完成不适用

New Strategies of Genetic Study of Patients With Oculocutaneous Albinism

University Hospital, Bordeaux0 个研究点目标入组 64 人开始时间: 2010年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
64
主要终点
Presence of a genetic anomaly

研究概览

简要总结

The oculocutaneous albinism is an autosomal recessive condition associated with mutations in 4 genes. In 20% of patients no mutation is identified. The optimization of genetic analysis methods and the search for new genes involved will help improve the diagnosis in these patients.

详细描述

The oculocutaneous albinism is an autosomal recessive condition associated with mutations in 4 genes. In 20% of patients no mutation is identified. The optimization of genetic analysis methods and the search for new genes involved will help improve the diagnosis in these patients.

.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Oculocutaneous albinism (diagnosis validated by a clinician at the initial genetic consultation and did not show mutations of the TYR, OCA2, TYRP1, SLC45A2 genes)

排除标准

  • 未提供

结局指标

主要结局

Presence of a genetic anomaly

时间窗: At the screening

Analysis by CGH (Comparative Genomic Hybridization) array : The Log2 values of the patient / reference fluorescence intensity ratios (Log2R) are -1 in the case of a heterozygous deletion, 0.5 in the case of heterozygous duplication and 0 in the absence of rearrangement.

Identification of a genetic mutation

时间窗: At the screening

By sequencing candidate genes : homozygotic cartography and candidate gene sequencing

次要结局

未报告次要终点

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

相似试验